Results 141 to 150 of about 1,955 (223)

Patient and carer perceptions and acceptability of current management practices in paediatric X-linked hypophosphatemia treated with burosumab therapy. [PDF]

JBMR Plus
Sandy JL, Rodda CP, Siafarikas A, Biggin A, Wall CL, Collins L, Schindeler A, Simm PJ, Munns CF.   +8 more
europepmc   +1 more source

Burosumab per al tractament de la hipofosfatèmia congènita

, 2021
Burosumab; X-linked hypophosphatemia; Hypophosphatemic rickets; Minority ...
openaire   +1 more source

Burosumab in adults with X-linked hypophosphatemia: real-world experience from a retrospective study in Sydney. [PDF]

JBMR Plus
Kumar S, Girgis CM, Tran B, Alvarez M, Clifton-Bligh RJ.   +4 more
europepmc   +1 more source

Treatment of Fibroblast Growth Factor-23-Mediated Renal Phosphate Wasting With Burosumab in a Patient With Chronic Kidney Disease 3b: A Case Report. [PDF]

Cureus
Goss CH, Earthineni G, Pasham V, Fülöp T.   +3 more
europepmc   +1 more source

First‐in‐Asian Phase I Study of the Anti‐Fibroblast Growth Factor 23 Monoclonal Antibody, Burosumab: Safety and Pharmacodynamics in Adults With X‐linked Hypophosphatemia [PDF]

, 2018
Hae Il Cheong, Han‐Wook Yoo, Masanori Adachi, Hiroyuki Tanaka, Ikuma Fujiwara, Yukihiro Hasegawa, Daisuke Harada, Maiko Sugimoto, Yosuke Okada, Masaki Kato, Ryutaro Shimazaki, Keiichi Ozono, Yoshiki Seino   +12 more
openalex   +1 more source

A case and review of fibroblast growth factor-23-mediated hypophosphatemic osteomalacia in the absence of pathogenic <i>PHEX</i> variants. [PDF]

JBMR Plus
Park YA, Gong JY, Chiang C, Trainer AH, Yates CJ.   +4 more
europepmc   +1 more source

Burosumab for Tumor-Induced Osteomalacia: Not Enough of a Good Thing [PDF]

, 2020
Iris R. Hartley, Michael T. Collins
openalex   +1 more source

Switching from active vitamin D and phosphate supplementation to burosumab significantly corrects lower limb malalignment in pediatric X-linked hypophosphatemia. [PDF]

J Bone Miner Res
Ward LM, Imel EA, Frumberg D, Dilworth L, Siener C, Chen Z, Krolczyk S, Carpenter TO, XLH Disease Monitoring Program Investigators .   +8 more
europepmc   +1 more source

Diagnosis, treatment, and management of rickets: a position statement from the Bone and Mineral Metabolism Group of the Italian Society of Pediatric Endocrinology and Diabetology [PDF]

De Sanctis, Luisa, Tessaris, Daniele
core   +1 more source

Two-year structural skeletal outcomes of burosumab therapy in pediatric X-linked hypophosphatemia: A radiographic cohort study. [PDF]

J Child Orthop
Lim H, Lee W, Choi N, Lee YJ, Shin CH, Lee YA, Ko JM, Song MH.   +7 more
europepmc   +1 more source